Skip to main content
. 2020 Jan 10;12:221–232. doi: 10.2147/CMAR.S232278

Figure 1.

Figure 1

Immunohistochemical staining of EphB3, ×200. (A) Positive expression of EphB3, well differentiated ECC. (B) Negative expression of EphB3, moderately- differentiated ECC. (C) Positive expression of EphB3, peritumoral tissues. (D) Positive expression of EphB3, adenoma.